Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Sodium iodate alters key epithelial-to-mesenchymal transition factors in human iPSC-derived RPE cells
Author Affiliations & Notes
  • Gregory Philip Campbell
    Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Yuanjun Zhao
    Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Jasmine Geathers
    Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Alistair J Barber
    Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Jeffrey Sundstrom
    Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Stephanie Louise Grillo
    Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   Gregory Campbell None; Yuanjun Zhao None; Jasmine Geathers None; Alistair Barber None; Jeffrey Sundstrom None; Stephanie Grillo None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 743. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gregory Philip Campbell, Yuanjun Zhao, Jasmine Geathers, Alistair J Barber, Jeffrey Sundstrom, Stephanie Louise Grillo; Sodium iodate alters key epithelial-to-mesenchymal transition factors in human iPSC-derived RPE cells. Invest. Ophthalmol. Vis. Sci. 2024;65(7):743.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Intraretinal hyperreflective foci (HRFs) appear on optical coherence tomographs (OCT) in retinal diseases such as Age-related Macular Degeneration (AMD). They are thought of as clinical indicators of disease severity. Sodium iodate (NaIO3) rapidly induces RPE degeneration in rodents, modeling characteristics of macular degeneration including HRFs. Recent studies from our lab and others have hypothesized that HRFs are RPE cells that have undergone epithelial-to-mesenchymal transition (EMT) and have migrated into the neural retina. The purpose of this study is to test whether NaIO3 alters the gene expression levels in human RPE-derived iPSC cells that drive them into the EMT process.

Methods : Human iPSCs were differentiated into RPE cells according to published protocols (from PMCID: PMC8784963 with minor modifications). On Day 150, mature RPE cells were treated with NaIO3 (2.5mM) for 72 hours. Cells were then lysed and processed using an RNA isolation kit. qPCR was used to quantify key markers of EMT, ER-stress, cytoskeleton, junction proteins, extracellular matrix, RPE signature genes and NRF2 targets.

Results : NaIO3 treatment significantly increased (p<0.05 to p<0.0001) selected EMT markers, including TGFB2, TGFBR1 and 2, SMAD 3 and 4, SNAI2, HES1, HEY1, HMGA2 and JAG1; Cytoskeleton marker, VIM; ER stress markers such as CANX; extracellular matrix markers such as FN1, MMP2, MMP9 and MMP14; and NRF2 targets (marker for oxidative stress) GCLM, HMOX1 and NQO1. NaIO3 treatment significantly reduced (p<0.01 to p<0.0001) RPE signature genes BEST1, CRALBP, RPE65, TRPM1, TYRP1 and tight junction proteins such as CDH1 and ZO-1.

Conclusions : NaIO3 increased NRF2 targets in RPE cells, which suggests that the cells were undergoing oxidative stress. EMT markers were increased following NaIO3 treatment, while RPE signature genes and tight junction proteins were decreased. Additionally, extracellular matrix markers were increased. The hallmark of EMT is cell migration, proliferation and excretion of extracellular matrix. Therefore, our results suggest that NaIO3 treatment induces oxidative stress in RPE cells and drives them into EMT, with the consequent loss of the RPE phenotype.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×